VEGFR2/CD309 anticorps (AA 1326-1356)
Aperçu rapide pour VEGFR2/CD309 anticorps (AA 1326-1356) (ABIN3028781)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1326-1356
-
Fonction
- VEGFR2 Antibody
-
Purification
- Purified
-
Immunogène
- A portion of amino acids 1326-1356 from the human protein was used as the immunogen for this VEGFR2 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the VEGFR2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the VEGFR2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- VEGFR2
-
Sujet
- KDR (FLK1) is a receptor for VEGF or VEGFC. This protein has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability.
-
UniProt
- P35968
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-